These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 30474770)

  • 1. Knowledge of cardiovascular disease risk factors and practice of primary prevention of cardiovascular disease by Community Pharmacists in Nigeria: a cross-sectional study.
    Amadi CE; Lawal FO; Mbakwem AC; Ajuluchukwu JN; Oke DA
    Int J Clin Pharm; 2018 Dec; 40(6):1587-1595. PubMed ID: 30474770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opportunistic screening of cardiovascular disease risk factors in community pharmacies in Nigeria: a cross-sectional study.
    Amadi C; Lawal F; Ajiboye W; Agbim R; Mbakwem A; Ajuluchukwu J; Oke DA
    Int J Clin Pharm; 2020 Dec; 42(6):1469-1479. PubMed ID: 32960427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knowledge, attitude, perceived barriers, and practices among pharmacists regarding risk assessment of cardiovascular disease: a cross-sectional study in Yemen.
    Al-Ashwal FY; Sulaiman SAS; Sheikh Ghadzi SM; Kubas MA; Halboup A
    Curr Med Res Opin; 2022 Mar; 38(3):451-459. PubMed ID: 34657524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An explanatory model of community pharmacists' support in the secondary prevention of cardiovascular disease.
    Puspitasari HP; Costa DSJ; Aslani P; Krass I
    Res Social Adm Pharm; 2016; 12(1):104-118. PubMed ID: 26001624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease.
    Puspitasari HP; Aslani P; Krass I
    Int J Clin Pharm; 2015 Oct; 37(5):834-43. PubMed ID: 25964140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of community pharmacists' preparedness for the provision of cardiovascular disease risk assessment and management services: A study with simulated patients.
    Zolezzi M; Abdallah O; Kheir N; Abdelsalam AG
    Res Social Adm Pharm; 2019 Mar; 15(3):252-259. PubMed ID: 29753643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Australian community pharmacists' awareness and practice in supporting secondary prevention of cardiovascular disease.
    Puspitasari HP; Aslani P; Krass I
    Int J Clin Pharm; 2013 Dec; 35(6):1218-28. PubMed ID: 24057435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Public knowledge and awareness of cardiovascular disease and its risk factors: a cross-sectional study of 1000 Jordanians.
    Mukattash TL; Shara M; Jarab AS; Al-Azzam SI; Almaaytah A; Al Hamarneh YN
    Int J Pharm Pract; 2012 Dec; 20(6):367-76. PubMed ID: 23134095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knowledge and practices of community pharmacists towards non-prescription dispensing of antibiotics in Northern Nigeria.
    Abubakar U; Tangiisuran B
    Int J Clin Pharm; 2020 Apr; 42(2):756-764. PubMed ID: 32270378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engaging community pharmacists in the primary prevention of cardiovascular disease: protocol for the Pharmacist Assessment of Adherence, Risk and Treatment in Cardiovascular Disease (PAART CVD) pilot study.
    Mc Namara KP; George J; O'Reilly SL; Jackson SL; Peterson GM; Howarth H; Bailey MJ; Duncan G; Trinder P; Morabito E; Finch J; Bunker S; Janus E; Emery J; Dunbar JA
    BMC Health Serv Res; 2010 Sep; 10():264. PubMed ID: 20819236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The knowledge, perceptions and practice of pharmacovigilance amongst community pharmacists in Lagos state, south west Nigeria.
    Oreagba IA; Ogunleye OJ; Olayemi SO
    Pharmacoepidemiol Drug Saf; 2011 Jan; 20(1):30-5. PubMed ID: 20845410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot study evaluating multiple risk factor interventions by community pharmacists to prevent cardiovascular disease: the PAART CVD pilot project.
    McNamara KP; O'Reilly SL; Dunbar JA; Bailey MJ; George J; Peterson GM; Jackson SL; Janus ED; Bunker S; Duncan G; Howarth H
    Ann Pharmacother; 2012 Feb; 46(2):183-91. PubMed ID: 22318928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Public knowledge of cardiovascular disease and its risk factors in Kuwait: a cross-sectional survey.
    Awad A; Al-Nafisi H
    BMC Public Health; 2014 Nov; 14():1131. PubMed ID: 25367768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a cardiovascular disease opportunistic risk assessment pilot ('Heart MOT' service) in community pharmacies.
    Horgan JM; Blenkinsopp A; McManus RJ
    J Public Health (Oxf); 2010 Mar; 32(1):110-6. PubMed ID: 19864496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of community pharmacists in health education and disease prevention: a survey of their interests and needs in relation to cardiovascular disease.
    O'Loughlin J; Masson P; Déry V; Fagnan D
    Prev Med; 1999 Mar; 28(3):324-31. PubMed ID: 10072752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Participation of Community Pharmacists in Primary Healthcare Services in Nigeria: A Mixed-Method Survey.
    Ihekoronye MR; Osemene KP
    Int J Health Policy Manag; 2022 Jun; 11(6):829-839. PubMed ID: 33300774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of pharmacist in cardiovascular disease-related health promotion and in hypertension and dyslipidemia management: a cross-sectional study in the State of Qatar.
    El Hajj MS; Mahfoud ZR; Al Suwaidi J; Alkhiyami D; Alasmar AR
    J Eval Clin Pract; 2016 Jun; 22(3):329-40. PubMed ID: 26552842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular disease prevention in rural Nigeria in the context of a community based health insurance scheme: QUality Improvement Cardiovascular care Kwara-I (QUICK-I).
    Hendriks M; Brewster L; Wit F; Bolarinwa OA; Odusola AO; Redekop W; Bindraban N; Vollaard A; Alli S; Adenusi P; Agbede K; Akande T; Lange J; Schultsz C
    BMC Public Health; 2011 Mar; 11():186. PubMed ID: 21439057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community Pharmacists, Pharmacy Counter Assistants and Oral Health Promotion in Plateau State, Nigeria.
    Taiwo OO
    West Afr J Med; 2021 Jun; 38(6):544-548. PubMed ID: 34174804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards cardiovascular disease prevention in Nigeria: A mixed method study of how adolescents and young adults in a university setting perceive cardiovascular disease and risk factors.
    Odunaiya NA; Adesanya T; Okoye EC; Oguntibeju OO
    Afr J Prim Health Care Fam Med; 2021 Apr; 13(1):e1-e9. PubMed ID: 33881332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.